BLT — BLIS Technologies Share Price
0.000.00%
Last trade - 00:00- NZ$17.91m
- NZ$9.40m
- NZ$11.53m
- 84
- 86
- 14
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.53 | ||
| Price to Tang. Book | 1.71 | ||
| Price to Free Cashflow | 14.32 | ||
| Price to Sales | 1.41 | ||
| EV to EBITDA | 4.32 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.61% | ||
| Return on Equity | 14.12% | ||
| Operating Margin | 12.88% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 10.64 | 10.61 | 8.96 | 10.23 | 11.53 | n/a | n/a | 6.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +329.41 | -64.38 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Blis Technologies Limited is a New Zealand-based manufacturer of advanced probiotic strains. The Company’s principal activity is developing healthcare products based on strains of bacteria that produce bacteriocin activity for sale in New Zealand and overseas. It delivers probiotic solutions for specific health targets, including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. Its probiotic portfolio includes BLIS K12, BLIS M18 and BLIS Q24. It sells ingredients and finishes goods to manufacturers and wholesale customers. The BLIS K12 (Streptococcus salivarius K12) is a probiotic to support the mouth and throat. The BLIS M18 (Streptococcus salivarius M18) is a probiotic to support teeth and gum health. The BLIS Q24 balances and restores the skin microbiome, restoring its natural health, clarity, and radiance. The Company’s products are sold throughout New Zealand and in Australia, Asia, Europe, and the United States.
Directors
- Peter Fennessy NEC
- Brian Watson CEO
- Geoffrey Philip Plunket VCH
- Richard Wingham CFO
- Laura Grant DMK
- Anthony Offen DRC
- Tom Roennlund DRC (48)
- Antony Balfour IND
- Aimee Mccammon IND
- Barry Richardson IND
- Alison Stewart IND
- Graeme Boyd NID
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- June 20th, 2000
- Public Since
- July 30th, 2001
- No. of Employees
- 10
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 1,279,301,599
- Address
- 399 Moray Place,, Dunedin Central, DUNEDIN, 9016
- Web
- https://blis.co.nz/
- Phone
- +64 34740988
- Auditors
- Deloitte Limited
Upcoming Events for BLT
BLIS Technologies Ltd Annual Shareholders Meeting
Similar to BLT
AFT Pharmaceuticals
New Zealand Stock Exchange
EBOS
New Zealand Stock Exchange
Rua Bioscience
New Zealand Stock Exchange
FAQ
What is the BLIS Technologies share price?
As of Today at 18:38 UTC, shares in BLIS Technologies are trading at NZ$0.01. This share price information is delayed by 15 minutes.
How has the BLIS Technologies share price performed this year?
Shares in BLIS Technologies last closed at NZ$0.01 and the price had moved by -6.67% over the past 365 days. In terms of relative price strength the BLIS Technologies share price has underperformed the ASX All Ordinaries Index by -7.97% over the past year.
What are the analyst and broker recommendations for BLIS Technologies?
There is no consensus recommendation for this security.
Find out moreWhat is the BLIS Technologies dividend yield?
BLIS Technologies does not currently pay a dividend.
Does BLIS Technologies pay a dividend?
BLIS Technologies does not currently pay a dividend.
When does BLIS Technologies next pay dividends?
BLIS Technologies does not currently pay a dividend.
How do I buy BLIS Technologies shares?
To buy shares in BLIS Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BLIS Technologies?
As of the previous close price of NZ$0.01, shares in BLIS Technologies had a market capitalisation of NZ$17.91m.
Where are BLIS Technologies shares listed?
Here are the trading details for BLIS Technologies:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: BLT
What kind of share is BLIS Technologies?
Based on an overall assessment of its quality, value and momentum BLIS Technologies is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BLIS Technologies share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the BLIS Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BLIS Technologies. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -31.49%.
As of the last closing price of NZ$0.01, shares in BLIS Technologies were trading -14.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BLIS Technologies PE Ratio?
The BLIS Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NZ$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BLIS Technologies?
BLIS Technologies' management team is headed by:
- Peter Fennessy - NEC
- Brian Watson - CEO
- Geoffrey Philip Plunket - VCH
- Richard Wingham - CFO
- Laura Grant - DMK
- Anthony Offen - DRC
- Tom Roennlund - DRC
- Antony Balfour - IND
- Aimee Mccammon - IND
- Barry Richardson - IND
- Alison Stewart - IND
- Graeme Boyd - NID